Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2784238rdf:typepubmed:Citationlld:pubmed
pubmed-article:2784238lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:2784238lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:2784238lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2784238lifeskim:mentionsumls-concept:C1155229lld:lifeskim
pubmed-article:2784238lifeskim:mentionsumls-concept:C0069216lld:lifeskim
pubmed-article:2784238lifeskim:mentionsumls-concept:C0205365lld:lifeskim
pubmed-article:2784238pubmed:issue2lld:pubmed
pubmed-article:2784238pubmed:dateCreated1989-4-20lld:pubmed
pubmed-article:2784238pubmed:abstractTextThe effects of 14-day treatment with low doses of O,S,S-trimethyl phosphorodithioate (OSS-TMP), an impurity in technical malathion, on the generation of cell-mediated and humoral immune responses were examined in female C57BL/6 mice. At a dose of 2.0 mg/kg per day OSS-TMP, the generation of antibody-secreting cells to sheep red blood cells, the generation of cytotoxic T lymphocytes (CTL) to alloantigen and the production of Interleukin-2 were elevated approximately 2-3 fold, while no changes were observed in the proliferative responses to the polyclonal activators, Concanavalin A, lipopolysaccharide, or phytohemagglutinin. In contrast, at 5.0 mg/kg per day OSS-TMP, both the CTL and specific antibody responses were suppressed, while all other immune parameters examined were unchanged. Data from cell separation and reconstitution experiments indicated that both T and B lymphocytes were affected by these treatment regimes. These data suggest that long-term exposure to low doses of OSS-TMP may enhance the ability of an animal to generate an immune response while higher doses of OSS-TMP may suppress the generation of an immune response.lld:pubmed
pubmed-article:2784238pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2784238pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2784238pubmed:languageenglld:pubmed
pubmed-article:2784238pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2784238pubmed:citationSubsetIMlld:pubmed
pubmed-article:2784238pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2784238pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2784238pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2784238pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2784238pubmed:statusMEDLINElld:pubmed
pubmed-article:2784238pubmed:monthFeblld:pubmed
pubmed-article:2784238pubmed:issn0300-483Xlld:pubmed
pubmed-article:2784238pubmed:authorpubmed-author:SternM LMLlld:pubmed
pubmed-article:2784238pubmed:authorpubmed-author:WareC FCFlld:pubmed
pubmed-article:2784238pubmed:authorpubmed-author:RodgersK EKElld:pubmed
pubmed-article:2784238pubmed:issnTypePrintlld:pubmed
pubmed-article:2784238pubmed:volume54lld:pubmed
pubmed-article:2784238pubmed:ownerNLMlld:pubmed
pubmed-article:2784238pubmed:authorsCompleteYlld:pubmed
pubmed-article:2784238pubmed:pagination183-95lld:pubmed
pubmed-article:2784238pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2784238pubmed:meshHeadingpubmed-meshheading:2784238-...lld:pubmed
pubmed-article:2784238pubmed:meshHeadingpubmed-meshheading:2784238-...lld:pubmed
pubmed-article:2784238pubmed:meshHeadingpubmed-meshheading:2784238-...lld:pubmed
pubmed-article:2784238pubmed:meshHeadingpubmed-meshheading:2784238-...lld:pubmed
pubmed-article:2784238pubmed:meshHeadingpubmed-meshheading:2784238-...lld:pubmed
pubmed-article:2784238pubmed:meshHeadingpubmed-meshheading:2784238-...lld:pubmed
pubmed-article:2784238pubmed:meshHeadingpubmed-meshheading:2784238-...lld:pubmed
pubmed-article:2784238pubmed:meshHeadingpubmed-meshheading:2784238-...lld:pubmed
pubmed-article:2784238pubmed:meshHeadingpubmed-meshheading:2784238-...lld:pubmed
pubmed-article:2784238pubmed:meshHeadingpubmed-meshheading:2784238-...lld:pubmed
pubmed-article:2784238pubmed:meshHeadingpubmed-meshheading:2784238-...lld:pubmed
pubmed-article:2784238pubmed:year1989lld:pubmed
pubmed-article:2784238pubmed:articleTitleEffects of subacute administration of O,S,S-trimethyl phosphorodithioate on cellular and humoral immune response systems.lld:pubmed
pubmed-article:2784238pubmed:affiliationLivingston Research Institute, USC School of Medicine, Los Angeles 90033.lld:pubmed
pubmed-article:2784238pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2784238pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed